Dr Lal PathLabs Overview

  • Year Founded
  • 1949

Year Founded

  • Status
  • Public

  • Employees
  • 5,611

Employees

  • Stock Symbol
  • LALPATHLAB

Stock Symbol

  • Investments
  • 15

  • Share Price
  • $21.23
  • (As of Monday Closing)

Dr Lal PathLabs General Information

Description

Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the areas of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist in preventing, monitoring, and treating diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 12th Floor, Tower B, SAS Tower
  • Medicity, Sector-38
  • Gurgaon, Haryana 122001
  • India
+91 011
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Clinics/Outpatient Services
Stock Exchange
NSE
Vertical(s)
Corporate Office
  • 12th Floor, Tower B, SAS Tower
  • Medicity, Sector-38
  • Gurgaon, Haryana 122001
  • India
+91 011

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dr Lal PathLabs Stock Performance

As of 16-Nov-2026, Dr Lal PathLabs’s stock price is $21.23. Its current market cap is $3.55B with 167M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$21.23 $21.19 $13.58 - $22.14 $3.55B 167M 285K $0.38

Dr Lal PathLabs Financials Summary

As of 30-Sep-2026, Dr Lal PathLabs has a trailing 12-month revenue of $327M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 3,344,691 2,190,197 2,302,711 2,185,991
Revenue 327,236 312,658 291,072 268,947
EBITDA 105,502 89,027 85,453 75,252
Net Income 62,932 57,125 57,610 43,212
Total Assets 359,975 333,430 317,607 294,503
Total Debt 23,248 21,090 18,404 29,610
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Dr Lal PathLabs Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dr Lal PathLabs‘s full profile, request access.

Request a free trial

Dr Lal PathLabs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other health
Laboratory Services (Healthcare)
Gurgaon, India
5,611 As of 2026

Mumbai, India
 

Navi Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dr Lal PathLabs Competitors (10)

One of Dr Lal PathLabs’s 10 competitors is Metropolis Healthcare, a Formerly PE-Backed company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Metropolis Healthcare Formerly PE-Backed Mumbai, India
Thyrocare Technologies Formerly PE-Backed Navi Mumbai, India
Oncquest Corporation Gurugram, India
Prognosis Laboratories Corporate Backed or Acquired New Delhi, India
Aspira Pathlab & Diagnostics Corporation Navi Mumbai, India
You’re viewing 5 of 10 competitors. Get the full list »

Dr Lal PathLabs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dr Lal PathLabs Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dr Lal PathLabs‘s full profile, request access.

Request a free trial

Dr Lal PathLabs Investments & Acquisitions (15)

Dr Lal PathLabs’s most recent deal was a Merger/Acquisition with SN Genelab for . The deal was made on 01-Oct-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SN Genelab 01-Oct-2026 Merger/Acquisition Hospitals/Inpatient Services
Sunshine Healthcare 26-Sep-2026 Merger/Acquisition Laboratory Services (Healthcare)
Shahbazkers Diagnostic Centre 01-May-2026 Merger/Acquisition Laboratory Services (Healthcare)
Dr Lal PathLabs (Four Unit Property in New Delhi, India) 23-Sep-2025 Corporate Asset Purchase Buildings and Property
Suburban Diagnostics 26-Oct-2021 Merger/Acquisition Laboratory Services (Healthcare)
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Dr Lal PathLabs ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

17.47 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Services

Subindustry

of 97

Rank

Percentile

To view Dr Lal PathLabs’s complete esg history, request access »

Dr Lal PathLabs Exits (1)

Dr Lal PathLabs’s most recent exit was on 26-Oct-2021 from Suburban Diagnostics. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Suburban Diagnostics 26-Oct-2021 Completed
To view Dr Lal PathLabs’s complete exits history, request access »

Dr Lal PathLabs Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Sunshine Healthcare Accra, Ghana 2010
SN Genelab Surat, India 1993
Shahbazkers Diagnostic Centre Mumbai, India 1980

Dr Lal PathLabs FAQs

  • When was Dr Lal PathLabs founded?

    Dr Lal PathLabs was founded in 1949.

  • Where is Dr Lal PathLabs headquartered?

    Dr Lal PathLabs is headquartered in Gurgaon, India.

  • What is the size of Dr Lal PathLabs?

    Dr Lal PathLabs has 5,611 total employees.

  • What industry is Dr Lal PathLabs in?

    Dr Lal PathLabs’s primary industry is Laboratory Services (Healthcare).

  • Is Dr Lal PathLabs a private or public company?

    Dr Lal PathLabs is a Public company.

  • What is Dr Lal PathLabs’s stock symbol?

    The ticker symbol for Dr Lal PathLabs is LALPATHLAB.

  • What is the current stock price of Dr Lal PathLabs?

    As of 16-Nov-2026 the stock price of Dr Lal PathLabs is $21.23.

  • What is the current market cap of Dr Lal PathLabs?

    The current market capitalization of Dr Lal PathLabs is $3.55B.

  • What is Dr Lal PathLabs’s current revenue?

    The trailing twelve month revenue for Dr Lal PathLabs is $327M.

  • Who are Dr Lal PathLabs’s competitors?

    Metropolis Healthcare, Thyrocare Technologies, Oncquest, Prognosis Laboratories, and Aspira Pathlab & Diagnostics are some of the 10 competitors of Dr Lal PathLabs.

  • What is Dr Lal PathLabs’s annual earnings per share (EPS)?

    Dr Lal PathLabs’s EPS for 12 months was $0.38.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process